POSB191 Modeled Impact of Nirsevimab Against Respiratory Syncytial Virus (RSV) Among French Infants Experiencing Their First RSV Season

Autor: Beuvelet, M, Hoestlandt, C, Lemaitre, M, Demont, C, Kieffer, A
Zdroj: In Value in Health January 2022 25(1) Supplement:S131-S131
Databáze: ScienceDirect